Skip to content
Abierto
Menu

Special notice

ATx Electroporator to Design Gene Editing Tools

75N92025Q00152

National Institutes of Health, National Institutes of Health Nhlbi. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

Maxcyte, Inc.

$55,200.00 obligated so far on USAspending

Description

As published on SAM.gov.

ATx Electroporator to Design Gene Editing Tools for In Vivo Gene Therapy

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Maxcyte, Inc.
UEI
KM8DZV21HFM8
CAGE
47CG7
Vendor location
Rockville, MD
Contract
75N92025P00397, purchase order
Obligated
$55,200.00
Actions
1 between September 26, 2025 and September 26, 2025
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Expert Atx Electroporation Platform, Generation 3 with Accessories (Region Specific Power Cord)
Match
solicitation number 75N92025Q00152 equals the FPDS solicitation identifier; same awarding office 75N920 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 15, 2025

    Special notice

    Due September 18, 2025 at 4:30 PM EDT. SAM.gov, notice 6a2d8b8edd784492bb2fedc8ac58c34e

Points of contact

Also open from this buyer